| Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Cell line
|
Drug
|
Regulatory
|
Confidence score(level)
|
Ref.
|
| acc1301 |
ERK2 |
phosphorylation |
Thr185 |
human |
Thyroid Cancer |
TPC-1 |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1302 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Thyroid Cancer |
TPC-1 |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1303 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
LOXIMVI |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1304 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
LOXIMVI |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1305 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
LOXIMVI |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1306 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
LOXIMVI |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1307 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
A375 |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1308 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
A375 |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1309 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
A375 |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1310 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
A375 |
TRAIL |
Enhancing |
5.0 (High)
|
25867065
|
| acc1311 |
ERK2 |
phosphorylation |
Thr185 |
human |
Thyroid Cancer |
LOXIMVI |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1312 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Thyroid Cancer |
LOXIMVI |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1313 |
ERK1 |
phosphorylation |
Thr202 |
human |
Thyroid Cancer |
BCPAP |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1314 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Thyroid Cancer |
BCPAP |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1315 |
ERK2 |
phosphorylation |
Thr185 |
human |
Thyroid Cancer |
BCPAP |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1316 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Thyroid Cancer |
BCPAP |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1317 |
ERK1 |
phosphorylation |
Thr202 |
human |
Thyroid Cancer |
TPC-1 |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1318 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Thyroid Cancer |
TPC-1 |
AMG655 |
Enhancing |
5.0 (High)
|
25867065
|
| acc1319 |
Chk1 |
phosphorylation |
Ser280 |
human |
Melanoma |
A375(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1320 |
Chk1 |
phosphorylation |
Ser280 |
human |
Melanoma |
WM9(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1321 |
Chk1 |
phosphorylation |
Ser296 |
human |
Melanoma |
A375(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1322 |
Chk1 |
phosphorylation |
Ser296 |
human |
Melanoma |
WM9(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1323 |
Chk1 |
phosphorylation |
Ser317 |
human |
Melanoma |
A375(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1324 |
Chk1 |
phosphorylation |
Ser317 |
human |
Melanoma |
WM9(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1325 |
Chk1 |
phosphorylation |
Ser345 |
human |
Melanoma |
A375(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1326 |
Chk1 |
phosphorylation |
Ser345 |
human |
Melanoma |
WM9(PLX4032-res) |
PLX4032 + PF477736 |
Associated |
4.0 (Moderate) |
30100999
|
| acc1327 |
ERK1 |
phosphorylation |
Thr202 |
human |
Melanoma |
SB01 |
Bafetinib + Trametinib |
Associated |
4.0 (Moderate) |
29717260
|
| acc1328 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Melanoma |
SB01 |
Bafetinib + Trametinib |
Associated |
4.0 (Moderate) |
29717260
|
| acc1329 |
ERK2 |
phosphorylation |
Thr185 |
human |
Melanoma |
SB01 |
Bafetinib + Trametinib |
Associated |
4.0 (Moderate) |
29717260
|
| acc1330 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Melanoma |
SB01 |
Bafetinib + Trametinib |
Associated |
4.0 (Moderate) |
29717260
|
| acc1331 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-231 |
Rapamycin |
Associated |
4.0 (Moderate) |
22422409
|
| acc1332 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-435 |
Rapamycin |
Associated |
4.0 (Moderate) |
22422409
|
| acc1333 |
AKT |
phosphorylation |
Thr308 |
human |
Breast Cancer |
MDA-MB-231 |
Rapamycin |
Associated |
4.0 (Moderate) |
22422409
|
| acc1334 |
AKT |
phosphorylation |
Thr308 |
human |
Breast Cancer |
MDA-MB-435 |
Rapamycin |
Associated |
4.0 (Moderate) |
22422409
|
| acc1335 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
OS2 |
Rapamycin |
Impairing |
5.0 (High)
|
20486173
|
| acc1336 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
OS9 |
Rapamycin |
Impairing |
5.0 (High)
|
20486173
|
| acc1337 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
OS17 |
Rapamycin |
Impairing |
5.0 (High)
|
20486173
|
| acc1338 |
eIF4E |
phosphorylation |
Ser209 |
human |
Prostate Cancer |
DU145 |
MNK-inh |
Associated |
4.0 (Moderate) |
18809972
|
| acc1339 |
eIF4E |
phosphorylation |
Ser209 |
human |
Prostate Cancer |
PC3 |
Rapamycin |
Associated |
4.0 (Moderate) |
18809972
|
| acc1340 |
eIF4E |
phosphorylation |
Ser209 |
human |
Prostate Cancer |
LNCaP |
Rapamycin |
Associated |
4.0 (Moderate) |
18809972
|
| acc1341 |
mTOR |
phosphorylation |
Ser2448 |
human |
Breast Cancer |
MCF7 |
Rapamycin |
Associated |
3.0 (Low)
|
30154572
|
| acc1342 |
claudin-7 |
phosphorylation |
Ser204 |
human |
Lung Cancer |
H522 |
Cisplatin |
Enhancing |
5.0 (High)
|
23433123
|
| acc1343 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-468 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1344 |
mTOR |
phosphorylation |
Ser2481 |
human |
Breast Cancer |
MDA-MB-468 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1345 |
FOXO3a |
phosphorylation |
Thr32 |
human |
Breast Cancer |
MDA-MB-468 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1346 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MDA-MB-231 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1347 |
mTOR |
phosphorylation |
Ser2481 |
human |
Breast Cancer |
MDA-MB-231 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1348 |
FOXO3a |
phosphorylation |
Thr32 |
human |
Breast Cancer |
MDA-MB-231 |
IBP OE |
Associated |
3.0 (Low)
|
24113176
|
| acc1349 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
A549 |
Resveratrol |
Associated |
4.0 (Moderate) |
31665911
|
| acc1350 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
A549 |
Resveratrol |
Associated |
4.0 (Moderate) |
31665911
|